Alumni – UW Bioengineering – Archive
Georgia Witchel and the team at Louiza Labs has raised $5million to develop the technology underlying simulated FDA trials and autonomous surgical robots.
Kamal Shah, Ph.D., a graduate of UW Bioengineering, is the lead author of a major new study that explores how smartwatches could help detect cardiac arrest.
UW Bioengineering alumnus Philip Lee: a circuitous journey of discovery and the path to medicine
Whether it is serving in the United States Army or working on breakthrough cancer therapies, Robb Poier (PharBE ‘23) has always been passionate about helping people and doing good in the world. more...
“My favorite [PharBE] class was also my most challenging class – Clinical Development – because it forced me to put in practice what I was learning,” Stephanie says. more...
Postdoc credits adviser Barry Lutz as example of resilience, collaboration.
A-Alpha Bio, a startup co-founded and led by UW Bioengineering alumni David Younger (Ph.D. ’17), and Randolph Lopez (Ph.D. ’18, received a $620,472 grant from the National Science Foundation to continue developing their AlphaSeq platform for the discovery of molecular glues.
UW Bioengineering alumna Jane Grande-Allen (Ph.D. ’98) has received the UW College of Engineering’s 2020 Diamond Award for Distinguished Achievement in Academia.
Nanodropper, a company co-founded by UW Bioengineering alumna Mackenzie Andrews, MS ’19, has completed this year’s Jones + Foster Accelerator program and received $25,000 in seed funding.
Nanodropper, a company co-founded by University of Washington Bioengineering alumna Mackenzie Andrews, MS ’19, has completed this year’s Jones + Foster Accelerator program and received $25,000 in seed funding.
UW Bioengineering alumnus Wayne Gombotz (M.S. ’85, Ph.D. ’88) has received the College of Engineering’s 2019 Diamond Award for Distinguished Achievement in Industry. Dr. Gombotz's work has provided the basis of many drug delivery strategies in use and development today; multiple successful therapeutic products and processes to treat cancer, infectious diseases and autoimmune diseases; and it spurred the development of the biotechnology industry in Seattle.
UW Bioengineering alumni Anna Blakney, Abbi Helfer, Emily Krogstad and Lael Wentland received Whitaker International Fellows and Scholars Program awards in 2016 to pursue independent research projects abroad. They talk about their experiences researching and living in England, Australia, South Africa and Vietnam.
Amanda Woodcock (B.S., '15) discusses discovering the field of product development as a senior at UW and how she decided to pursue the field as a career. "I love being in the trenches, brainstorming and coming up with solutions to the most difficult problems,"
UW Bioengineering Ph.D. program alumnus Alex Jiao’s startup Silene Biotech wants to help you to grow a new heart or liver – in case those organs fail later in life.
In this professional master's degree program, students gain cutting-edge knowledge in basic bioscience, drug discovery and pharmaceutics, and learn how to apply their expertise to market-based demands of pharmaceutical industry.
A drive to engineer solutions to global health problems compelled recent Yager lab Ph.D. graduate Joshua Buser to pursue bioengineering. He aims to bring diagnostic testing to low-resource settings – and increase access to affordable health care closer to home.
UW Bioengineering faculty James Lai, Suzie Pun and Patrick Stayton, and BioE Ph.D. alumnus and affiliate faculty member Patrick Hsieh, are among contributing authors of a paper describing a novel treatment for limb ischemia.
Dr. Kelly Stevens, an assistant professor in UW Bioengineering and in Pathology, has received a 2016 National institutes of Health (NIH) Director’s New Innovator Award in support of her work to build artificial human tissues from stem cells, and to remotely control these tissues after implantation in a patient.
UW Bioengineering eNews offers an update on our advances in bioengineering research and education, and recognizes recent achievements of our students and faculty.
Alumnus Michael Garrison (Ph.D., ’99) won UW's 2016 Diamond Award for Distinguished Achievement in Industry. Now vice president of R&D at Becton Dickinson and Co., Dr. Garrison has inspired and developed medical products that have improved health care safety, disease management and infection prevention around the world.
UW Bioengineering alumna and recipient of 2015-16 Fulbright Student and Whitaker fellowships Sharon Newman is investigating ways to design and build durable, longer lasting neuroprosthetic electrodes. She is also learning German and exploring Europe in her free time.
